Shorter serial intervals in SARS-CoV-2 cases with Omicron BA.1 variant compared with Delta variant, the Netherlands, 13 to 26 December 2021
2022; European Centre for Disease Prevention and Control; Volume: 27; Issue: 6 Linguagem: Inglês
10.2807/1560-7917.es.2022.27.6.2200042
ISSN1560-7917
AutoresJantien A. Backer, Dirk Eggink, Stijn P. Andeweg, Irene Veldhuijzen, Noortje van Maarseveen, Klaas Vermaas, Boris Vlaemynck, Raf Schepers, Susan van den Hof, Chantal Reusken, Jacco Wallinga,
Tópico(s)COVID-19 Clinical Research Studies
ResumoThe SARS-CoV-2 Omicron variant has a growth advantage over the Delta variant because of higher transmissibility, immune evasion or shorter serial interval. Using S gene target failure (SGTF) as indication for Omicron BA.1, we identified 908 SGTF and 1,621 non-SGTF serial intervals in the same period. Within households, the mean serial interval for SGTF cases was 0.2-0.6 days shorter than for non-SGTF cases. This suggests that the growth advantage of Omicron is partly due to a shorter serial interval.
Referência(s)